Ruvuna, L. & Sood, A. Epidemiology of chronic obstructive pulmonary disease. Clin. Chest Med. 41, 315–327 (2020).
Calverley, P. M. A. & Walker, P. P. Contemporary concise review 2022: chronic obstructive pulmonary disease. Respirology 28, 428–436 (2023).
Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052–2090 (2018).
Papaporfyriou, A. et al. Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy. Life 13, 1299 (2023).
Chen, W., Thomas, J., Sadatsafavi, M. & FitzGerald, J. M. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir. Med. 3, 631–639 (2015).
Konecny, T. et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am. J. Cardiol. 114, 272–277 (2014).
Simons, S. O. et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur. Heart J. 42, 532–540 (2021).
Zobdeh, A., Hoyle, D. J., Shastri, P., Bezabhe, W. M. & Peterson, G. M. Prevention of new-onset heart failure in atrial fibrillation: the role of pharmacological management. Am. J. Cardiovasc. Drugs 25, 147–155 (2025).
Linz, D. et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg. Health Eur. 37, 100786 (2024).
Corlateanu, A. et al. Multidimensional indices in the assessment of chronic obstructive pulmonary disease. Respir. Med. 185, 106519 (2021).
Joglar, J. A. et al. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. J. Am. Coll. Cardiol. 83, 109–279 (2024).
Sircu, V. et al. The burden of comorbidities in obstructive sleep apnea and the pathophysiologic mechanisms and effects of CPAP. Clocks Sleep. 5, 333–349 (2023).
Ergül, T. et al. Prognostic accuracy of DECAF and ottawa COPD risk scores in patients presenting to the emergency department with COPD exacerbation. J. Acute Med. 15, 11–18 (2025).
Kotlyarov, S. & Lyubavin, A. Early detection of atrial fibrillation in chronic obstructive pulmonary disease patients. Medicina 60, 352 (2024).
Warming, P. E. et al. Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk. Eur. Heart J. Qual. Care Clin. Outcomes 9, 128–134 (2023).
Vogelmeier, C. F. et al. Comorbidities and cause of death in COPD patients compared to Non-COPD controls: an 8-year observational retrospective healthcare claims database cohort study. Int. J. Chron. Obstruct Pulmon Dis. 20, 2117–2130 (2025).
Pham, H. N. et al. Incidence of arrhythmias in chronic obstructive pulmonary disease, obstructive sleep apnea, and overlap syndrome: A retrospective cohort study. Heart Rhythm. 22, e650–e657 (2025).
Méndez-Bailón, M. et al. Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. an observational study using hospital discharge data in Spain (2004-2013). Int. J. Cardiol. 236, 209–215 (2017).
Mathioudakis, A. G. et al. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS task force study protocol. ERJ Open. Res. 6, 00193–02020 (2020).
Shin, S. Y., Manuel, A. R. G. & Lip, G. Y. H. Atrial fibrillation and End-Stage COPD: a close association revisited. Chest 155, 888–889 (2019).
Huang, T., Huang, X., Cui, X. & Dong, Q. Predictive nomogram models for atrial fibrillation in COPD patients: A comprehensive analysis of risk factors and prognosis. Exp. Ther. Med. 27, 171 (2024).
MacDonald, D. M. et al. Continuous monitoring for atrial fibrillation in individuals at increased risk of acute exacerbations of COPD. Am. J. Respir. Crit. Care Med. 211, 868–870 (2025).
Bartlett-Pestell, S., Wong, T. & Wedzicha, J. A. Exacerbating the Problem: COPD and Atrial Fibrillation. Am. J. Respir. Crit. Care Med. 211, 695–697 (2025).
Zysman, M. et al. Risk of cardiovascular events according to the severity of an exacerbation of chronic obstructive pulmonary disease. Eur. J. Prev. Cardiol. 32, 1436–1444 (2025).
Nguyen, H. L., Nguyen, T. D. & Phan, P. T. Prevalence and associated factors of paroxysmal atrial fibrillation and atrial arrhythmias during hospitalizations for exacerbation of COPD. Int. J. Chron. Obstruct Pulmon Dis. 19, 1989–2000 (2024).
Vahdatpour, C. A., Luebbert, J. J. & Palevsky, H. I. Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension. Pulm. Circ. 10, 2045894020910685 (2020).
Huang, Q. et al. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ 8, e10376 (2020).
Chen, C. Y. & Liao, K. M. The impact of atrial fibrillation in patients with COPD during hospitalization. Int. J. Chron. Obstruct Pulmon Dis. 13, 2105–2112 (2018).
Grymonprez, M. et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int. J. Cardiol. 276, 118–124 (2019).
Sarkar, M., Niranjan, N. & Banyal, P. K. Mechanisms of hypoxemia. Lung India 34, 47–60 (2017).
Hirata, A. Effect of hypoxia on electrical activity of atrioventricular nodal cells and atrial cells of the rabbit’s heart. J. Electrocardiol. 23, 69–76 (1990).
Senges, J. et al. Effect of hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ. Res. 44, 856–863 (1979).
Lin, Y. K. et al. Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. Clin. Sci. 122, 121–132 (2012).
Nattel, S. & Harada, M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J. Am. Coll. Cardiol. 63, 2335–2345 (2014).
Babapoor-Farrokhran, S., Gill, D., Alzubi, J. & Mainigi, S. K. Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines. Mol. Cell Biochem. 476, 2283–2293 (2021).
Yao, C. et al. Enhanced Cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation 138, 2227–2242 (2018).
Gramley, F. et al. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc. Pathol. 19, 102–111 (2010).
Ogi, H. et al. Is structural remodeling of fibrillated atria the consequence of tissue hypoxia? Circ. J. 74, 1815–1821 (2010).
O’Driscoll, B. R., Howard, L. S., Davison, A. G. & British Thoracic S. BTS guideline for emergency oxygen use in adult patients. Thorax 63, vi1–vi68 (2008).
Al Wachami, N. et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public. Health 24, 297 (2024).
Goudis, C. A., Konstantinidis, A. K., Ntalas, I. V. & Korantzopoulos, P. Electrocardiographic abnormalities and cardiac arrhythmias in chronic obstructive pulmonary disease. Int. J. Cardiol. 199, 264–273 (2015).
Sarkar M., Madabhavi I., Kadakol N. Oxygen-induced hypercapnia: physiological mechanisms and clinical implications. Monaldi Arch Chest Dis. 93 https://doi.org/10.4081/monaldi.2022.2399 2022.
Stevenson, I. H. et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 7, 1263–1270 (2010).
Terzano, C. et al. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur. Rev. Med. Pharmacol. Sci. 18, 2908–2917 (2014).
Huang, B. et al. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. J. Am. Med. Dir. Assoc. 15, 576–581 (2014).
Proietti, M. et al. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation (EORP-AF) General Registry. Am. Heart J. 181, 83–91 (2016).
Goudis, C. A. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J. Cardiol. 69, 699–705 (2017).
Naser, N. et al. The impact of risk factors and comorbidities on the incidence of atrial fibrillation. Mater. Sociomed. 29, 231–236 (2017).
Weitzenblum, E., Chaouat, A. & Kessler, R. Pulmonary hypertension in chronic obstructive pulmonary disease. Pneumonol. Alergol. Pol. 81, 390–398 (2013).
Kallergis, E. M., Goudis, C. A. & Vardas, P. E. Atrial fibrillation: a progressive atrial myopathy or a distinct disease? Int. J. Cardiol. 171, 126–133 (2014).
Hu, Y. F., Chen, Y. J., Lin, Y. J. & Chen, S. A. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiology 12, 230–243 (2015).
Chung, M. K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104, 2886–2891 (2001).
Hayashi, T. et al. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease. Europace 15, 1777–1783 (2013).
Roder, F. et al. Interactions of sleep apnea, the autonomic nervous system, and its impact on cardiac arrhythmias. Curr. Sleep. Med. Rep. 4, 160–169 (2018).
van Gestel, A. J. & Steier, J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J. Thorac. Dis. 2, 215–222 (2010).
Stewart, A. G., Waterhouse, J. C. & Howard, P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur. Respir. J. 4, 1207–1214 (1991).
Chhabra, S. K. & De, S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir. Med. 99, 126–133 (2005).
Promsrisuk, T. et al. Oxidative stress associated with impaired autonomic control and severity of lung function in chronic obstructive pulmonary disease patients. J. Exerc. Rehabil. 19, 75–84 (2023).
Cavaillès, A. et al. Comorbidities of COPD. Eur. Respir. Rev. 22, 454–475 (2013).
Chamberlain, A. M. et al. Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study. Heart Rhythm. 8, 1160–1166 (2011).
Cunningham, T. J., Ford, E. S., Rolle, I. V., Wheaton, A. G. & Croft, J. B. Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. Copd 12, 276–286 (2015).
Heeringa, J., Kors, J. A., Hofman, A., van Rooij, F. J. & Witteman, J. C. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am. Heart J. 156, 1163–1169 (2008).
Seccia, T. M. & Calò, L. A. Smoking causes atrial fibrillation? further evidence on a debated issue. Eur. J. Prev. Cardiol. 25, 1434–1436 (2018).
Comments (0)